Carfilzomib produces OS benefit vs. bortezomib in relapsed, refractory disease March 30, 2017Vol.40 No.03
Drugs & Targets Bavencio receives accelerated approval for Merkel cell carcinoma March 24, 2017Vol.43 No.12
In Brief Levine Cancer Institute launches first mobile lung CT unit in the U.S. March 24, 2017Vol.43 No.12
In Brief Robert Wechsler-Reya named RCIGM’s program director for neuro-oncology March 24, 2017Vol.43 No.12
In Brief Patil named first-ever Chief Data Officer of the Year by CDO Club March 24, 2017Vol.43 No.12
In Brief Sanofi Genzyme extends Multiple Myeloma Journey Partners Program to cities nationwide March 24, 2017Vol.43 No.12
Conversation with The Cancer Letter Fran Visco: We should be partners on every level, not just when the NIH budget is threatened March 24, 2017Vol.43 No.12By Paul Goldberg
